ORASURE TECHNOLOGIES, INC State and Local Income Tax Expense (Benefit), Continuing Operations
ORASURE TECHNOLOGIES, INC (OSUR) reported State and Local Income Tax Expense (Benefit), Continuing Operations of $26.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Income Tax
us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations · last filed 2026-08-07
- ORASURE TECHNOLOGIES, INC state and local income tax expense (benefit), continuing operations for the quarter ending 2026-06-30 was $26.00K, a 98.91% decline year-over-year.
- ORASURE TECHNOLOGIES, INC state and local income tax expense (benefit), continuing operations for the quarter ending 2026-03-31 was $28.00K, a 211.11% increase year-over-year.
- ORASURE TECHNOLOGIES, INC state and local income tax expense (benefit), continuing operations for the quarter ending 2025-12-31 was $108.00K, a 65.05% decline year-over-year.
- ORASURE TECHNOLOGIES, INC state and local income tax expense (benefit), continuing operations for the quarter ending 2025-09-30 was -$612.00K, a 3500.00% decline year-over-year.
- ORASURE TECHNOLOGIES, INC state and local income tax expense (benefit), continuing operations for fiscal 2025 was $1.90M, a 1800.00% increase from fiscal 2024.
- ORASURE TECHNOLOGIES, INC state and local income tax expense (benefit), continuing operations for fiscal 2024 was $100.00K, a 94.74% decline from fiscal 2023.
- ORASURE TECHNOLOGIES, INC state and local income tax expense (benefit), continuing operations for fiscal 2023 was $1.90M, a 90.00% increase from fiscal 2022.
- ORASURE TECHNOLOGIES, INC state and local income tax expense (benefit), continuing operations for fiscal 2022 was $1.00M, a 400.00% increase from fiscal 2021.
| Period end | State and Local Income Tax Expense (Benefit), Continuing Operations 3 month | State and Local Income Tax Expense (Benefit), Continuing Operations 6 month | State and Local Income Tax Expense (Benefit), Continuing Operations 9 month | State and Local Income Tax Expense (Benefit), Continuing Operations 12 month | State and Local Income Tax Expense (Benefit), Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $26.00K 10-Q · filed 2026-08-07 | $54.00K 10-Q · filed 2026-08-07 | $162.00K derived: sum of 3 quarters · filed 2026-08-07 | -$450.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | $28.00K 10-Q · filed 2026-05-08 | $136.00K derived: sum of 2 quarters · filed 2026-05-08 | -$476.00K derived: sum of 3 quarters · filed 2026-05-08 | $1.92M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | $108.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$504.00K derived: sum of 2 quarters · filed 2026-03-09 | $1.89M derived: sum of 3 quarters · filed 2026-08-07 | $1.90M 10-K · filed 2026-03-09 | |
| 2025-09-30 | -$612.00K 10-Q · filed 2025-11-05 | $1.78M derived: sum of 2 quarters · filed 2026-08-07 | $1.79M 10-Q · filed 2025-11-05 | $2.10M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | $2.39M 10-Q · filed 2026-08-07 | $2.40M 10-Q · filed 2026-08-07 | $2.71M derived: sum of 3 quarters · filed 2026-08-07 | $2.73M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | $9.00K 10-Q · filed 2026-05-08 | $318.00K derived: sum of 2 quarters · filed 2026-05-08 | $336.00K derived: sum of 3 quarters · filed 2026-05-08 | $339.00K derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | $309.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $327.00K derived: sum of 2 quarters · filed 2026-03-09 | $330.00K derived: sum of 3 quarters · filed 2026-03-09 | $100.00K 10-K · filed 2026-03-09 | |
| 2024-09-30 | $18.00K 10-Q · filed 2025-11-05 | $21.00K derived: sum of 2 quarters · filed 2025-11-05 | -$209.00K 10-Q · filed 2025-11-05 | -$697.00K derived: sum of 4 quarters · filed 2026-03-09 | |
| 2024-06-30 | $3.00K 10-Q · filed 2025-08-06 | -$228.00K 10-Q · filed 2025-08-06 | -$715.00K derived: sum of 3 quarters · filed 2026-03-09 | $416.00K derived: sum of 4 quarters · filed 2026-03-09 | |
| 2024-03-31 | -$230.00K 10-Q · filed 2025-05-07 | -$718.00K derived: sum of 2 quarters · filed 2026-03-09 | $413.00K derived: sum of 3 quarters · filed 2026-03-09 | $1.89M derived: sum of 4 quarters · filed 2026-03-09 | |
| 2023-12-31 | -$488.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $643.00K derived: sum of 2 quarters · filed 2026-03-09 | $2.12M derived: sum of 3 quarters · filed 2026-03-09 | $1.90M 10-K · filed 2026-03-09 | |
| 2023-09-30 | $1.13M 10-Q · filed 2024-11-06 | $2.61M derived: sum of 2 quarters · filed 2024-11-06 | $2.39M 10-Q · filed 2024-11-06 | $3.01M derived: sum of 4 quarters · filed 2025-03-07 | |
| 2023-06-30 | $1.48M 10-Q · filed 2024-08-06 | $1.26M 10-Q · filed 2024-08-06 | $1.88M derived: sum of 3 quarters · filed 2025-03-07 | $1.84M derived: sum of 4 quarters · filed 2025-03-07 | |
| 2023-03-31 | -$225.00K 10-Q · filed 2024-05-09 | $396.00K derived: sum of 2 quarters · filed 2025-03-07 | $356.00K derived: sum of 3 quarters · filed 2025-03-07 | $539.00K derived: sum of 4 quarters · filed 2025-03-07 | |
| 2022-12-31 | $621.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $581.00K derived: sum of 2 quarters · filed 2025-03-07 | $764.00K derived: sum of 3 quarters · filed 2025-03-07 | $1.00M 10-K · filed 2025-03-07 | |
| 2022-09-30 | -$40.00K 10-Q · filed 2023-11-08 | $143.00K derived: sum of 2 quarters · filed 2023-11-08 | $379.00K 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | $183.00K 10-Q · filed 2023-08-04 | $400.00K 10-Q · filed 2023-08-04 | |||
| 2022-03-31 | $955.00K 10-K · filed 2023-03-03 | ||||
| 2021-12-31 | $200.00K 10-K · filed 2024-03-11 | $163.00K 10-K · filed 2023-03-03 | |||
| 2020-12-31 | -$794.00K 10-K · filed 2023-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |